Project Grant R43DA063260
Award Date
4/1/25
Completion Date
3/31/26
Dollars Obligated
$386K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Utah, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $586,936 to Vitan-Biotech LLC, a minority-owned biotechnology company, to develop a low-cost, disposable, point-of-use urine test strip that enables rapid quantification of substance use disorder (SUD) medication drugs and their metabolites. The goal is to create a sensitive and specific non-instrument test that can measure...
The National Institute on Drug Abuse (NIDA) awarded Labsys LLC, a for-profit limited liability company, a $294,474 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a wearable continuous drug monitoring device for opioid use disorders (CDM-MOUD). The objective is to create a low-cost, painless wearable patch that can monitor medication levels in interstitial fluid, providing uninterrupted insights into the effectiveness of opioid use disorder treatment...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under CFDA Program 93.279 "Drug Use and Addiction Research Programs" provides $295,606.00 in funding to Ricovr Healthcare Inc. to develop a point-of-need (PON) device called "Xaliva" for accurate and destigmatized detection of recent cannabis use.
The key products or services being developed through this award include a plasmonic fiber-optic absorbance biosensor (P-FAB) and an immunoassay-based...
This $636,344 cooperative agreement awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop and commercialize a new point-of-care technology to improve methadone dosing for the treatment of opioid use disorders (OUDs). The project will leverage novel, non-invasive sensors to rapidly evaluate a patient's methadone metabolism rate and enable more individualized dosing decisions, with the goal of reducing withdrawal...
The National Institute on Drug Abuse (NIDA) awarded a $399,589 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Resilient Lifescience, Inc., a for-profit organization located in Allegheny-West, PA. The grant, awarded on Sep 15, 2024, supports the development of a wearable medical device to detect opioid overdose. The project is scheduled for completion by Aug 31, 2025. The Drug Use and Addiction Research Programs provide funding for a wide range of substance...
This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $275,253 to Epivario Inc. for the period of September 30, 2024 to September 29, 2025. The funding will support research and development efforts to identify a novel epigenetic regulator as a potential treatment for opioid use disorder (OUD). Epivario, a biotechnology research company, will screen next-generation inhibitors of the metabolic...
The National Science Foundation (NSF) Division of Electrical, Communications and Cyber Systems awarded a $399,541 Project Grant to the Trustees of Dartmouth College to develop a high-throughput, label-free, and portable sensor that can quantitatively detect multiple illicit drugs including opioids, cocaine, psychostimulants, and methadone in liquid samples such as biofluids. The project aims to create a silver or gold nanoparticle-decorated zinc oxide nanorod coated silica nanofiber matrix...
The National Institute on Drug Abuse (NIDA) awarded Tenvos Inc., a minority-owned and woman-owned small business, a $800,000 Project Grant under CFDA 93.279 - Drug Use and Addiction Research Programs. The grant will support the development of a software-based medical device to detect opioid use through voice analysis. The proposed solution will enable patients to remotely screen for opioid use using a smartphone app and securely transmit the results to their clinicians, which aims to improve...
This $591,752 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop a digital platform to improve the delivery of opioid risk screening and safety interventions in community pharmacies. The grant will provide tablets to pharmacies currently using a paper-based screening tool, allowing for the collection of additional data on patient interactions that can be analyzed to assess the functionality...
The federal Cooperative Agreement award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $800,000 to support the development, clinical validation, and commercialization of ODALERT - a wearable device for the automatic detection of opioid-induced respiratory arrest.
The project, led by Biosensics LLC, aims to address the urgent public health need for effective interventions to reduce opioid overdose mortality....